High dose rate prostate brachytherapy

RADIATION3 trials

Sponsors

British Columbia Cancer Agency

Conditions

Localized Prostate CarcinomaProstate Cancer

Phase 3

Comparison of HDR vs. LDR Brachytherapy as Monotherapy for Intermediate Risk Prostate Cancer

Active, not recruitingNCT02692105

British Columbia Cancer AgencyProstate Cancer

Start: 2016-05-01End: 2028-12-01Updated: 2026-06-29

Unknown Phase

LDR vs. HDR Brachytherapy for Prostate Cancer

Active, not recruitingNCT03426748

British Columbia Cancer AgencyProstate Cancer

Start: 2018-02-15End: 2034-10-31Updated: 2026-01-29

Multi-omic Approach to Study HDR Brachytherapy for Favorable Risk and Low Tier Intermediate Risk Prostate Cancer

RecruitingNCT06200974

British Columbia Cancer AgencyLocalized Prostate Carcinoma

Start: 2024-02-01End: 2038-02-01Target: 100Updated: 2026-02-02